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The eﬀect of Hibiscus sabdariﬀa L. (Hs) calyx extract on fat absorption-excretion and body weight in rats, was investigated. Rats
were fed with either a basal diet (SDC = Control diet) or the same diet supplemented with Hs extracts at 5%, 10% and 15% (SD5,
SD10 and SD15). Only SD5 did not show signiﬁcant increases in weight, food consumption and eﬃciency compared to SDC.T h e
opposite occurred in SD15 group which showed a signiﬁcant decrease for these three parameters. The SD10 responses were similar
to SD15,withtheexceptionoffoodconsumption.InbothSDC andSD5 groups,nobodyweightlosswasobserved;however,onlyin
the latter group was there a signiﬁcantly greater amount of fatty acids found in feces. A collateral eﬀect emerging from the study is
that components of Hs extract at the intermediate and greater concentrations used in this experiment could be considered possible
antiobesity agents.
Copyright © 2009 O. Carvajal-Zarrabal et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The scientiﬁc groups carrying out studies on Hibiscus
sabdariﬀa L. family Malvaceae calyx ethanol extract in order
to ascertain its physiological activity-structure relationship
are generally located in areas where it is used in food
applications and traditional medicine [1]. Advances in these
studies can be divided into three lines: therapeutic eﬀects
on lipid metabolism [2–8]; antihypertensive eﬀects [9–13];
apoptoticeﬀectsingastriccarcinomacells[14,15].Inseveral
of the studies, [2, 4, 6, 8–11, 13] no extract standardization is
reported, although a tendency is observed to overcome this
deﬁciency. Besides the calyx, H. sabdariﬀa L. leaf has also
been subjected to this type of scientiﬁc studies, particularly
leaf ethanolic extracts, which have been found to inﬂuence
lipid metabolism [16–20].
Hs calyx extract contains hibiscus acid, or (+)-hydro-
xycitric acid, known as (+)-HCA [21–23]. Its isomer,
(−)-hydroxycitric acid or (−)-HCA, the active ingredient
principle present in Garcinia indica and Garcinia cambogia
fruits, is an inhibitor of citrate lyase [24, 25], and because
of this, it has been proposed as an anti-obesity agent [25–
30]. Tee et al. [31] reported that hydroxycitric acid (no
isomer speciﬁed), present in Hs calyx extract, inhibits fat
production from carbohydrates in experiments carried out
on rats. In addition, Carvajal-Zarrabal et al. [6]s u g g e s t e d
that racemization of (+)-HCA to (−)-HCA by the intestinal
ﬂora may be a possible explanation to warrant the signiﬁcant
decrease in triacylglycerols in the experiment carried out
on rats supplemented with Hs extract. This proposal agrees
with the generalization made by Borriello et al. [32], which
establishes that phytochemicals absorbed in the intestine
can be transformed by colonic bacteria, resulting in serum
components diﬀerent from the original phytochemicals.
Therapeutic eﬀects reported in studies carried out on
animal models supplemented with Roselle, Hibiscus sabdar-
iﬀa L. extracts include its inﬂuence on lipid metabolism as2 Journal of Biomedicine and Biotechnology
Table 1: Composition of basal and experimental diets. Experimen-
tal diets are Basal diet plus Hibiscus sabdariﬀa ethanol calyx extract
(Diet formulated according to AIN-93G formulation).
Ingredient Basal diet (g)
Cornstarch 35.5
Casein 20.0
Dextrinized cornstarch 13.2
Sucrose 10.0
Cellulose 5.0
Mineral mix AING-93 G 3.5
Vitamin mix AING-93 G 1.0
L-Cysteine 0.30
Choline bitartrate 0.25
Ter-butylhydroquinone 0.014
Lard 10.0
Cholesterol 1.0
Cholic acid 0.25
well as its antihypertensive and apoptotic actions. The aim
of the present study was to research the action of Hs calyx
extract on fat absorption, excretion, and body weight, as no
information was encountered referring speciﬁcally to these
aspects of lipid metabolism.
2.MaterialsandMethods
2.1. Plant Material and Extract Preparation. The air dried
calyces along with a sample of the ﬂowering plant of
Hibiscus sabdariﬀa were acquired from the local market in
Veracruz, Mexico. The sample was authenticated as Hibiscus
sabdariﬀa L. by Prof. Sergio Avenda˜ no and registered as
O.Carvajal 001 at the Herbarium of the Ecology Institute
A.C., Xalapa, Veracruz. Mexico. The calyces (135g) were
placed in a ﬂask and 500mL (96%) ethanol were added.
The content was left for 8 days, with an occasional shaking
to increase the extraction capacity. The macerated substance
wasﬁlteredandconcentratedinarotaryevaporatorat38
◦C.
The solid mass obtained from the evaporated extract was
approximately 7.5% w/v. The concentrated plant extract was
stored at 4
◦C until used. Its viscosity at 25
◦C was 1200c.p.
2.2. Animals and Diets. T h ee x p e r i m e n t a lp r o t o c o lf o r
animal experiments was approved by the Animal Ethic
Committee, Chemical-Biology Area, University of Veracruz
(Program:Hibiscus sabdariﬀaPart I 2004–2008). Forty Male
Sprague-Dawley rats (6 weeks old, 250 to 350g in weight)
were purchased from Harlan Teklad, Co. (Mexico City)
and individually housed in stainless steel mesh cages in
a temperature-controlled room (22–25
◦C regulated by an
electronic timer) with a 12-hours light/dark cycle. They had
free access to food and non-ionized water throughout the
feeding period. The basal diet was prepared according to
the American Institute of Nutrition [33] and is shown in
Table 1. Lard (10g/100g diet) was employed as the source
of dietary fat, and cholesterol and cholic acid were added
at 1 and 0.25g/100g diet, respectively. The experimental
diet is the basal diet plus ethanol dried extract of Hibiscus
sabdariﬀa calyces at levels of 5, 10, and 15g of extract/100g
diet. Animals were fed the basal diet for one week in order to
develop an atherogenic condition (cholesterol ≥ 220mg/dL,
atherogenic index deﬁned as total cholesterol, cHDL/cHDL
≥ 2.5). Thereafter, they were divided into four groups (10
rats each). The control group (SDC) was maintained on
the basal diet and three groups of rats, designated as SD5,
SD10,S D 15, received the respective experimental diet for
4 weeks. The parameters that were quantiﬁed are directly
related to the digestive process and its eﬀects; as this lasts
approximately 3 hours, its eﬀect on body weight can be
measured with conﬁdence and reproducibility within an
experimental period of 4 weeks. Diets were prepared once
a week and stored in powdered form at 4◦C until feeding.
Bodyweightandfoodintakeweremeasureddaily.Feceswere
collected during the last 5 days and freeze-dried. At the end
of the experimental period, diets were withdrawn for at least
four hours.
2.3. Determination of Fat in Feces. F e c a lf a t sw e r ee x t r a c t e d
according to the method of Jeejeebhoy et al. [34]. Brieﬂy,
1g freeze-dried feces was acidiﬁed with 2 drops concentrated
HCltoreleasefreefattyacids,andsequentiallyextractedwith
solvent No.1 (heptane: diethyl ether: 95% ethanol = 1:1:
1) and solvent No.2 (heptane: diethyl ether: 95% ethanol:
water = 1 : 1 : 1 : 1). The lipid extract was vacuum dried
(Gallenkamp Oven Mod. UAF- 570-0300) and weighed. The
apparent absorption rate (%) of dietary fat was calculated
as 100 × [amount of daily fatty acid intake − amount
of fecal fatty acids excreted]/[amount of daily fatty acid
intake]. To identify the individual fatty acids excreted into
the feces, the lipid extract was saponiﬁed with an ethanol-
KOH solution, and the saponiﬁed fatty acids were acidiﬁed
with an HCl solution, diluted with an equal volume of H2O,
a n dm e t h y l a t e dw i t ha nH 2SO4/MeOH solution (1 : 115) as
described by Ikeda et al. [35]. Fatty acids were determined
by gas chromatography (Hewlett Packard 5890, Palo Alto,
CA.) with pentadecanoic acid as an internal standard. All
chemicals used were analytical grade.
2.4. Statistical Analysis. T h eo b t a i n e dd a t aw e r ee x p r e s s e d
as mean ± standard deviation of means (x ± SD). A one-
way analysis of variance (ANOVA) was used to compare
the means of the studied groups with post hoc Duncan
multiple range tests at 5% and 1% for those results where
a signiﬁcant diﬀerence was indicated. Minitab version 12
statistical software was used.
3. Results
3.1. Atherogenic Condition, Growth, and Diet Consump-
tion Parameters. Animals fed the basal diet attained an
atherogenic condition, their levels of cholesterol and their
atherogenic index being 481 ± 82 mg/dL and 6.1, respec-
tively. Table 2 shows growth, food consumption, and weight
parameters for both the control group SDC and the threeJournal of Biomedicine and Biotechnology 3
Table 2: Growth parameters and fecal weight in rats treated with Hibiscus sabdariﬀa L. extract, A one-way analysis of variance (ANOVA)
was used to compare the means of the studied groups with post hoc Duncan multiple range tests at 5% and 1% for those results where a
signiﬁcant diﬀerence was indicated.
Parameters Dietary groups
Control (SDC)S D 5 SD10 SD15
Initial body weight (g) 260 ± 7 261 ± 11 338 ± 10 261 ± 2
Final body weight (g) 307 ± 9 306 ± 11 356 ± 11 267 ± 4
Body weight gain (g) 47 ± 74 5 ± 51 8 ±4
∗∗ 6 ±2∗∗
Food intake (g/d) 14.5 ± 0.3 14.2 ± 0.8 13.8 ± 0.6 12.1 ± 1.1∗
Food eﬃciency (g body weight gain/g food intake) 3.2 ± 0.6 3.2 ± 0.3 1.3 ± 0.3∗ 0.5 ± 0.2∗∗
Fecal dry weight (g/d) 1.25 ± 0.08 1.42 ± 0.12∗ 0.81 ± 0.05∗∗ 0.75 ± 0.09∗∗
Statistical diﬀerences ( ∗P <. 05; ∗∗P <. 01), when compared with the control group.
Table 3: Apparent fat absorption and fecal fat excretion in rats fed with H. sabdariﬀa L. extract, A one-way analysis of variance (ANOVA)
was used to compare the means of the studied groups with post hoc Duncan multiple range tests at 5% and 1% for those results where a
signiﬁcant diﬀerence was indicated.
Parameters Dietary groups
Control SDC SD5 SD10 SD15
Fatty acid absorption (%) 95.1 ± 0.31 91.4 ± 1.01∗∗ 93.6 ± 1.83 95.2 ± 0.89
Fatty acid excretion (μmol/d)
14 : 0 7 ± 11 2 ± 15 ±1
∗∗ 5 ±1∗∗
16 : 0 20 ± 4 396 ± 40∗∗ 140 ±7∗ 89 ±6∗
16 : 1 8 ± 11 0 ± 19 ± 19 ± 1
18 : 0 289 ± 97 437 ± 58∗∗ 55 ±5∗∗ 33 ±5∗∗
18 : 1 8 ± 16 2 ±9
∗∗ 17 ±2
∗ 14 ±1∗
18 : 2 (n-6) 9 ± 11 8 ±2
∗∗ 18 ±2
∗∗ 18 ±1∗∗
Statistical diﬀerences ( ∗P <. 05; ∗∗P <. 01), when compared with the control group.
experimental groups supplemented with Hs extract (SD5,
SD10,a n dS D 15). No signiﬁcant diﬀerences were observed
betweentheexperimentalgroupsandcontrolasregardsbody
weight; however, body weight gain in SD10 and SD15 groups
was signiﬁcantly less (P<. 01) than in control group SDC.
Food consumption in the experimental groups (SD5,S D 10,
SD15) decreased with Hs extract dose, but this only became
signiﬁcant (P<. 05) in the SD15 group. Food eﬃciency for
the SD5 group was the same as for control SDC;h o w e v e r ,
for SD10 and SD15 groups, a signiﬁcant decrease in this
parameter was observed (P<. 05 and P<. 01, resp.)
compared to control. Feces weight (g/d) in all experimental
groups varied signiﬁcantly compared to the control, with a
signiﬁcant increase (P<. 05) observed in the SD5 treated
group and a signiﬁcant decrease (P<. 01) in the SD10 and
SD15 treated groups.
3.2. Apparent Fecal Fat Absorption and Excretion. The results
shown in Table 3 reﬂect the eﬀect of the diet the animals
weresubjectedtointhisstudy,concerningfatabsorptionand
excretion. In the case of SD5, fat absorption was signiﬁcantly
lower (P<. 01) compared to control group SDC.At e n d e n c y
toward higher excretion was observed in the fecal fatty acid
proﬁles of experimental groups, as compared to control.
Speciﬁcally, SD5 group showed an increase for all fatty acids
in feces, signiﬁcantly so for 16:0 (palmitic), 18 : 0 (stearic),
18 : 1 (oleic), and 18 : 2 (n-6) (linoleic). Fatty acids measured
in groups SD10 and SD15 showed an increase in four cases:
16 : 0 (palmitic), 16 : 1 (palmitoleic), 18 : 1 (oleic), and 18
: 2 (n-6) (linoleic); only for palmitoleic was the increase not
signiﬁcant.
4. Discussion
Both experimental (SD5,S D 10,a n dS D 15) and control (SDC)
groups were fed ad libitum.O n l yS D 5 group did not show a
signiﬁcant diﬀerence in the three parameters studied: weight
gain, food consumption, and eﬃciency, as compared to
control. These results were diﬀerent between groups SD5
and SD15,S D 5 showing behavior similar to control, while
in SD15 a signiﬁcant decrease in all three parameters was
observed. SD10 was similar to SD15, except in the case of
food consumption. Considering food eﬃciency comprises
both weight gain and food consumption, and that, as a
result, dietary components and their eﬀect on body weight
are related; it is evident that Hs extracts, at intermediate and
greater concentrations used in these experiments (SD10 and
SD15), by not increasing body weight, reveal themselves as
potential antiobesity agents.
On the other hand, the SD5 group absorbed the least
amount of fat, exhibited an increase in all fatty acids in feces
resulting from fat hydrolysis, and did not lose weight, the4 Journal of Biomedicine and Biotechnology
latter behavior being similar to control. Fatty acid excretion
in SDC, however, was less than in SD5 group. One possible
explanation for this behavior in control and SD5 groups,
where weight gain was similar though with diﬀerential
lipid excretion, could be due to weight gain in SD5 group
basically through carbohydrate absorption; this assumes that
Hs extract components at this level of concentration do not
exert an inhibitory eﬀect on pancreatic amylase.
Lower weight gain in SD10 and SD15 groups, added
to their similar total lipid absorption, though diﬀerent in
excreted fatty acid type (greater palmitic, oleic, and linoleic
and lower stearic acids as compared to control) seems to
indicate that at these concentrations Hs extract components
could inhibit pancreatic amylase, as reported by Hansawasdi
et al. [36, 37], who identiﬁed Hibiscus acid, or (+)-HCA, as
responsible for this action. This would consequently prevent
polysaccharide unfolding and absorption. Mention should
be made of the signiﬁcant decrease in food consumption
observed in the SD15 group, possibly related to a dietary
palatability problem when Hs extract concentration was
increased. Signiﬁcantly increased C16:0 excretion, observed
in all groups, is attributable to Hs extract chemical com-
ponents. It is relevant to recall that the fat administered in
this experiment was lard, rich in triacylglicerols with C16:0
in sn-2 position. Renaud et al. [38] observed that C16:0
interesteriﬁcation in fat triacylglycerols results in a greater
fat secretion in experimental animal feces accompanied by
a decrease in TAG and cholesterol levels, including HDL
cholesterol. We consider that this result is due to, amongst
other factors, the speciﬁcity of lingual and gastric lipases
which hydrolyse esters in positions 1 and 3, the latter being
twice as susceptible as the former. In order to explain the
eﬀect of Hs extract chemical components, in their original
state or modiﬁed by the intestinal ﬂora, on increased C16:0
concentration (20, 7, and 4.5 times in SD5,S D 10,a n dS D 15,
respectively, compared to SDC), as observed in the present
study of fecal fat, the following hypotheses are proposed:
inactivation of lipases; impediment of 2-monoacylglycerol
uptake into the enterocyte, due to a competitive saturation
of the speciﬁc transport system [39], or interesteriﬁcation
of the C16:0 from sn-2 to sn-1 or sn-3. Validation of these
hypotheses requires further study.
It can be concluded that animals kept on a diet sup-
plemented with Hs calyx ethanol extract showed signiﬁcant
C16:0 excretion in feces. The three hypotheses proposed
to explain this excretion need subsequent testing and
validation. Besides, a collateral eﬀect emerging from the
study is that Hs extract components at the intermediate
and greater concentrations used in this experiment could
be considered possible anti-obesity agents, through their
tendency to inhibit α-amylase.
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